The MCMP significantly eases the administrative burden of prescribing Medicinal Cannabis products; by pre-populating all applicable approval forms, recording patient details required for repeat prescriptions, and providing ready access to a wealth of clinical studies to support your application.
The MCMP links together the prescriber, the pharmacy and the supplier to ensure your patients receive full support and continuity of care throughout their treatment.
Frequently Asked Questions:
Registering to the MCMP is quick and straightforward. Simply click on the Register button on the toolbar and follow the registration prompts. Alternatively, click here.
You will need to provide some basic information, such as your name, main clinic address and AHPRA number which will assist us in generating the appropriate forms required to comply with all regulatory requirements.
If you have any questions you can contact the MCMP Administration Team who will be happy to talk you through the requirements.
Input your details and submit your application
A member of the MCMP Admin Team will review your application within 2 working days
You will be sent an account activation email with your username. Click on the link to set your password
Patients must provide informed consent to be registered to the MCMP, as their details will be accessible by the prescriber, and by their nominated pharmacy.
To register a patient in the MCMP you will need to log in using your own username and password, and follow the system prompts.
Log in to MCMP
Explain MCMP to patient
Obtain consent from patient
Input patient details and confirm
Give a copy of the Patient Leaflet to your patient
When the patient has been successfully registered a unique Patient ID number will be generated. This Patient ID number will be logged against your profile for future reference.
Because personal information is captured during the registration process, it is critical to ensure that you obtain consent from the patient or their carer to participate in the MCMP, as well as obtaining fully informed consent to prescribe a Medicinal Cannabis product.
MCMP Network Pharmacies have agreed to access Medicinal Cannabis products from participating manufacturers and dispense these products at no more than the listed price.
Please click here to access the MCMP Network Pharmacy locator.
In order to prescribe Medicinal Cannabis, prescribers must ensure that they have approval from both the TGA and their State Health Authority.
TGA Approval may be obtained either through Approved Clinical Trials, the Authorised Prescriber Scheme, or the Special Access Scheme. The MCMP facilitates supply of Medicinal Cannabis through the Authorised Prescriber Scheme and the Special Access Scheme – Category B.
State Approvals may vary depending on a variety of factors, e.g whether the medication is schedule 4 or schedule 8, or if the applicant is a specialist or a General Practitioner.
The MCMP considers these requirements and only generates the paperwork relevant for your application.
It is therefore important to ensure that you keep your information up-to-date. To change any of your details please contact the MCMP Administration Team.
Please note: While PharmaPrograms makes every effort to ensure the MCMP is up to date we also recommend that you familiarise
yourself with the requirements applicable to your state/territory.
There are a number of links to research articles contained within the MCMP that relate to Medicinal Cannabis. We aim to support all registered healthcare providers, doctors and pharmacists, in their continued professional development.
You can also view the regulatory requirements via the Department of Health website for your state/territory:
These links to external websites are not provided or maintained by, or in way affiliated with PharmaPrograms or Sinapse Pty Ltd. PharmaPrograms and Sinapse Pty Ltd do not guarantee the accuracy, relevance, timeliness or completeness of any information on these external websites.
All supporting collateral relating to the MCMP can be found here.
Please be aware that all material is intended for use by registered Prescribers only, and there is a password required to access this information. If you have misplaced your log in details, please contact the MCMP Administration team who will be able to assist you.
Lists available Medicinal Cannabis products from MCMP Participant Companies
Pre-fills approval forms to minimise administration time
Records all details for future reference. (Pre-populates patient details)
Provides direct link to chosen MCMP Network pharmacy to ensure optimal continuity of care
Provides ongoing reference of treatment outcomes and patient medication history regarding Medicinal Cannabis.
The Commonwealth Department of Health, in conjunction with state and territory governments, has helped coordinate the development new clinical guidance documents for prescribers of medicinal cannabis products for treating chemotherapy-induced nausea and vomiting, epilepsy, multiple sclerosis, chronic non-cancer pain and palliative care, as well as an overview document:
- Guidance for the use of medicinal cannabis in Australia: Patient information
- Guidance for the use of medicinal cannabis in Australia: Overview
- Guidance for the use of medicinal cannabis in the treatment of multiple sclerosis in Australia
- Guidance for the use of medicinal cannabis in the treatment of palliative care patients in Australia
- Guidance for the use of medicinal cannabis in the treatment of epilepsy in paediatric and young adult patients in Australia
- Guidance for the use of medicinal cannabis for the prevention or management of nausea and vomiting in Australia
- Guidance for the use of medicinal cannabis in the treatment of chronic non-cancer pain in Australia
These guidance documents will be updated iteratively when new evidence emerges.
General practitioners (GPs) who have any questions about prescribing medical cannabis through the Special Access Scheme or Authorised Prescriber Scheme can ring the special TGA Medicinal Cannabis Hotline for GPs:
Phone: 1800 020 653 (Monday – Friday, 9am-5pm)
A list of Medicinal Cannabis products from participating manufacturers is available here.